Proteomic biomarkers differentiate bacterial infections in febrile infants: A multicentre prospective study
Open Access
- 3 June 2026
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 93 (1) , 106782
Abstract
No abstract availableKeywords
Funding Information
- Royal College of Emergency Medicine (RCEM 02/03/2021)
- Sir Halley Stewart Trust
This publication has 38 references indexed in Scilit:
- Diagnostic test accuracy of dipstick urinalysis in clean catch urine for urinary tract infection in febrile infants presenting to emergency departments: a post-hoc analysis of the FIDO studyeClinicalMedicine, 2025
- Performance of clinical decision aids (CDA) for the care of young febrile infants: a multicentre prospective cohort study conducted in the UK and IrelandeClinicalMedicine, 2024
- Validation of a multi-analyte immunoassay for distinguishing bacterial vs. viral infections in a pediatric cohortClinica Chimica Acta, 2023
- Detection of serum human neutrophil lipocalin is an effective biomarker for the diagnosis and monitoring of children with bacterial infectionDiagnostic Microbiology and Infectious Disease, 2023
- A point-of-need platform for rapid measurement of a host-protein score that differentiates bacterial from viral infection: Analytical evaluationClinical Biochemistry, 2022
- Frequency of serious bacterial infections in young infants with and without viral respiratory infectionsThe American Journal of Emergency Medicine, 2021
- Infant Immune Response to Respiratory Viral InfectionsImmunology and Allergy Clinics of North America, 2019
- A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial InfectionsJAMA Pediatrics, 2019
- A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or YoungerJAMA, 2016